IFNA1 and hepatocellular carcinoma: We also reported the clinical efficiency of IFN-α and 5-fluorouracil (5-FU) combination therapy for advanced HCC with portal venous tumor thrombi and intrahepatic metastasis (9–11), including the mechanism of the anti-tumor effect (12–19).